These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9554383)
21. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565 [TBL] [Abstract][Full Text] [Related]
22. [Prostate-specific membrane antigen and its role in diagnosis of prostate cancer]. Chekhonin VP; Grigor'ev ME; Zhirkov IuA; Lebedev DV Vopr Med Khim; 2002; 48(1):31-43. PubMed ID: 12068496 [TBL] [Abstract][Full Text] [Related]
23. [Detection of PSA mRNA in prostate cancer patients' blood]. Ito T; Okubo Y; Tachibana M Rinsho Byori; 2001 Oct; 49(10):974-7. PubMed ID: 11769474 [TBL] [Abstract][Full Text] [Related]
24. Reliability of PSA circulating cells as markers of metastatic prostate cancer. Cardillo MR; Di Silverio F; Gentile V Scand J Clin Lab Invest; 2004; 64(7):687-89. PubMed ID: 15513326 [No Abstract] [Full Text] [Related]
25. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]. Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911 [TBL] [Abstract][Full Text] [Related]
26. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer. Gandhok NK; Looney S; Koochekpour S; Sartor O Urol Oncol; 2005; 23(3):163-7. PubMed ID: 15907715 [TBL] [Abstract][Full Text] [Related]
27. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A. Wang Q; Zheng JY; Kreth J; Yan X; Kamata M; Campbell RA; Xie Y; Chiu R; Berenson JR; Shi W; Chen IS; Pang S Urology; 2009 May; 73(5):1119-25. PubMed ID: 18602143 [TBL] [Abstract][Full Text] [Related]
28. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA]. de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270 [TBL] [Abstract][Full Text] [Related]
29. Re: Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy. Singh A Can J Urol; 2009 Jun; 16(3):4659. PubMed ID: 19497173 [No Abstract] [Full Text] [Related]
30. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma. Lucotte G; Mercier G; Burckel A Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660 [TBL] [Abstract][Full Text] [Related]
31. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas. Ghossein RA; Carusone L; Bhattacharya S In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082 [TBL] [Abstract][Full Text] [Related]
32. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. Davis JW; Nakanishi H; Kumar VS; Bhadkamkar VA; McCormack R; Fritsche HA; Handy B; Gornet T; Babaian RJ J Urol; 2008 Jun; 179(6):2187-91; discussion 2191. PubMed ID: 18423725 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells. Burchill SA; Perebolte L; Johnston C; Top B; Selby P Br J Cancer; 2002 Jan; 86(1):102-9. PubMed ID: 11857020 [TBL] [Abstract][Full Text] [Related]
35. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. Stoffel JT; Topjian L; Libertino JA BJU Int; 2005 Aug; 96(3):313-5. PubMed ID: 16042720 [TBL] [Abstract][Full Text] [Related]
36. Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. Kosari F; Asmann YW; Cheville JC; Vasmatzis G Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1419-26. PubMed ID: 12433721 [TBL] [Abstract][Full Text] [Related]
37. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Jung K; Henke W; Lein M; Schnorr D; Loening SA Cancer; 1996 Dec; 78(11):2445-8. PubMed ID: 8941018 [No Abstract] [Full Text] [Related]